BIO SAN FRANCISCO: the biggest event in the biopharma sector
From 6 to 8 June 2016, Biocat coordinated the Catalan delegation to the BIO International Convention, the top biotechnology partnering event in the world, which was held at Moscone Center in San Francisco (California, United States). This region is known for its strong presence in the areas of biopharmaceutical products, industrial biotechnology, biofuels, medical devices and diagnostics.
Once again, Biocat was key in organizing the presence of the BioRegion of Catalonia at the fair, in collaboration with ICEX (Spanish Institute for Foreign Trade), the statewide coordinating body. A total of 42 companies and organizations from Catalonia participated, five more than in 2015 (33 companies and 9 research or innovation-support bodies). Like every year, the BioRegion had its own booth, located right by the Business Forum area and next to the fair’s main sponsors.
The event brought pharmaceutical and biotechnology companies, consultancy and service firms, and research organizations together in the United States. Five of these companies had their own booth in the BioRegion of Catalonia pavilion: Archivel Pharma, Bcn Peptides, Salvat Biotech, Trifermed CBDO and ZeClinics. Grífols opted to have a booth outside of the Spanish pavilion. The fair also featured veteran participants, like Bioibérica, Bionure, GP Pharm, Plasmia Biotech and Oryzon Genomics. Others were there for the second year in a row, like Molomics, VHIR and Som Biotech. Participating for the first time were DBGen, Institute for Health Science Research Germans Trias i Pujol (IGTP) and IDP Pharma.
Activities at the pavilion
On the first day of the fair, ICEX held an event called Spain Kicks off BIO 2016: Innovation in Biotech. From translation, transfer and licensing through spin-out and VC financing. The panel discussion featured experts from the sector –including representatives from Eli Lilly, Roche and Stanford University– speaking about developing strategies and best business practices, as well as the best strategies for each type of product. The pavilion also hosted a networking reception.
The 42 Catalan companies and organizations that attended the fair, with their own booth or coordinated by Biocat, broken down by area of activity, were:
Biotechnology - Therapeutics & Diagnostics: Ability Pharma, Archivel Pharma, Bionure, DBGen, GP Pharm, IDP Pharma, Minoryx Therapeutics, Molomics, Oryzon Genomics, SOM Biotech, Spherium Biomed and Thrombotargets Europe.
Biotechnology - Other: AB-Biotics and Biochemize.
Organizations: ACCIO - Catalonia Trade & Investment, Biocat, BIST, Center for Genomic Regulation (CRG), CREB (UPC), Institute for Health Science Research Germans Trias i Pujol, IRB Barcelona, Autonomous University of Barcelona and Vall d'Hebron Research Institute.
Catalan delegation booth at BIO Convention 2016, in San Francisco.
On the cutting edge of the sector
New this year, we negotiated a discount on Convention Access & Partnering tickets, instead of partnering tickets for the exhibition area, as had been done previously. This allowed our organizations to set up meetings in the Business Forum, gaining access to higher-level executives and cutting down on time spent moving between meetings. The fair also extended the number of days available for partnering, so companies had more hours available for meetings.
BIO was an excellent environment to forge synergies with top executives and opinion leaders: the one-on-one partnering meetings, as always, were one of the main draws of this event, setting new records. A total of 35,700 partnering meetings were held at the event, which welcomed 15,937 industry leaders from 76 different countries. The educational program featured 800 speakers in 157 sessions covering the latest business opportunities, medical discoveries and ecosystems, among other topics.
For more information on the highlights of the sessions, go to: www.biotech-now.org.